Paola Belardi RN has reviewed some key abstracts from the European Oncology Nursing Society meeting (EONS15) at ESMO 2022.  She shares her thoughts on the conclusions and implications for nursing practice.  Watch the video for the key highlights and download the slides for the detailed data.


Paola Belardi RN reviews the following key abstracts:

  • Nutriscore: Nutritional screening in colorectal cancer patients previous to cancer specific treatment (Abstract CN13)
  • Workplace violence against cancer nurses during the COVID-19 pandemic: a correlational-predictive study (Abstract CN35)
  • Individual factors leading to delay in diagnosis in patients with colorectal cancer and their illness perceptions (Abstract CN15)
  • Understanding the treatment experiences of adults diagnosed with early-onset colorectal cancer: a qualitative study (Abstract 1434P)

GI NURSES CONNECT Update from EONS15 and ESMO 2022

I am Paola Belardi, a Nurse Co-ordinator in San Donato Hospital, Arezzo Oncology. I am here to provide you with an update from ESMO EONS 2022 on behalf of GI NURSES CONNECT.

The abstracts that I chose were about Nutriscore, which is a nutritional screening tool used in colorectal cancer patients, workplace violence against cancer nurses, Individual factors leading to delayed diagnosis in colorectal cancer patients and life experience of early onset colorectal cancer patients.

The first abstract is about Nutriscore. Nutriscore is a nutritional screening tool used in colorectal cancer patients. I selected this abstract because I think the systematic use of a screening tool can help nurses to manage to prevent malnutrition. As a matter of fact, in this study, ninety two persons were enrolled during their first oncology nursing visit, and Nutriscore was calculated. When the score was higher or equal than five, the person was referred to a clinical nutrition unit. And the importance of this action is that the nurse can detect a potential nutritional problem before starting the cancer treatment, so it can help the success of the treatment itself and the well-being of the patient.

The second abstract is about workplace violence against cancer nurses. It is well known that workplace violence can affect in a negative way, the healthcare organisations and nurses are the most exposed health care professionals. So this study detects, which are the main risk factors of this phenomenon. For example, use of substances, alcohol abuse, mental health disorders and emotional concerns. But also a violence can be increased by a higher number of patients. So this study tells us that it is really important to invest on prevention strategies with a great involvement of cancer nurses.

The other abstract is about Individual factors leading to delayed diagnosis in colorectal cancer patients. I selected it because nurses need to know more about this kind of delayed diagnosis in order to prevent it as much as possible, The purpose of this study is to notice the time elapsed between the onset of the first symptoms and the diagnosis itself. And it found out that the sixty percent of the patients waited more than one month, and half of them waited even more than three months with a great delay.

So the main motivation they assumed was they didn't know the specific signs and symptoms of colorectal cancer. So this study tells us that we need to invest on patient education in order to get an earlier diagnosis and more therapeutical chances.

The last abstract talks about a qualitative study about the life experience of early onset colorectal cancer patients. It is extremely interesting to know how they feel, and how they cope with this diagnosis. In fact, this study involved twenty one persons, and all of them reported negative feelings such as anxiety, body, image and fertility concerns. And so they also spoke about online forum and community social media as a way of comfort and support for themselves and their family. So this study highlights that there is a lack of specific care for this kind of patient, and that more holistic care is required, especially regarding mental health issues and fertility counselling.

I wish for the nursing community to continue the effort on colorectal cancer research for our improvement, for the quality of life of our patients. And I think GI NURSES CONNECT can really help us to do so.

I hope this little contribute was useful and enjoyable for you, and I thank you for your attention also on behalf of GI NURSES CONNECT.

Paola Belardi is a Nurse Co-ordinator at San Donato Hospital in Arezzo, Italy. Paola gained her first level Nursing Degree at the University of Siena in 2000. Later, in 2002 she attended a Public Health class at the University of Florence and in 2010 she graduated the Master Degree in Management at the University of Siena. In 2013 she started her work in oncology setting and now she is principally committed in activities such as nurse staffing and quality standard in oncology. From 2018 she is also an adjunct professor teaching Oncology Nursing at the University of Siena. Her professional interests are: chemotherapy and target therapy side effects management, intravenous devices management and nurses education. In the last month she has been co-supervisor of two Nursing Degree thesis: one studying the nurses’ role in fatigue prevention and the other regarding the nurses’ level of knowledge about simultaneous care model.

Programme summary
Watch the video now
Share this programme
This educational programme is supported by an Independent Medical Education Grant from Bayer
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
GI NURSES CONNECT

GI NURSES CONNECT is an initiative of COR2ED, supported by Independent Educational Medical Grants from Bayer and Eisai Europe Limited.

Meet the experts

Other programmes of interest

Other
Oncology 
The evolving role of liquid biopsy in biomarker testing

Clinical application of liquid biopsy, and how it applies to NSCLC, breast and colorectal cancer

Experts
Assoc. Prof. Umberto Malapelle
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Jul 2024

Educational programme supported by an Independent Medical Education grant from Bayer.
Interactive patient case
Oncology 
Advanced renal cell carcinoma: Managing a long-term durable response

Maximising outcomes for patients with advanced RCC 

Experts
Prof. Michael Staehler
Endorsed by
Urobel VZW | ASBL
  • clock 15 MIN
  • calendar Jun 2024

Educational programme supported by an Independent Medical Education grant from Eisai Europe Limited.
Other

Episode

1

of 1

episode
Oncology 
Overcoming pre-analytical phase challenges in gastric, prostate and lung cancer

Medical experts make recommendations for best practice

Experts
Dr Alexander Wyatt, Prof. Frédéric Bibeau
Endorsed by
AMP
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Jun 2024

Educational programme supported by an Independent Medical Education grant from AstraZeneca and Amoy Diagnostics.
Conference update
Oncology 
Oncogene-addicted NSCLC: Highlights from ASCO 2024

The latest non-small cell lung cancer data presented at ASCO

Experts
Prof. Nicolas Girard
  • download Downloadable
    Resources
  • clock 3 MIN
  • calendar Jun 2024

Educational programme supported by an Independent Medical Education grant from Bayer.
Upper lower GI cancer update ASCO 2024 Conference update
Oncology 
Upper and lower GI cancer update from ASCO 2024

GI oncologists review the latest data presented at ASCO 2024

Experts
Dr Samuel J Klempner, Dr Elizabeth Smyth, Prof. Jenny Seligmann, Dr Dominik Modest
  • clock 8 MIN
  • calendar Jun 2024

Educational programme supported by an Independent Medical Education grant from Bayer.
Experts Knowledge Share Video
Oncology Hemato-oncology 
Optimising the management of multiple myeloma in the early relapsed/refractory setting (RRMM)

Medical experts discuss the latest learnings from clinical practice

Experts
Prof. Aurore Perrot, Prof. Hermann Einsele, Assoc. Prof. Karthik Ramasamy, Assoc. Prof. Joshua Richter
  • download Downloadable
    Resources
  • clock 76 MIN
  • calendar Jun 2024

Educational programme supported by an Independent Medical Education grant from Menarini Stemline Oncology.